SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-243083
Filing Date
2020-09-10
Accepted
2020-09-10 16:02:34
Documents
12
Period of Report
2020-09-10
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d938653d8k.htm   iXBRL 8-K 21838
  Complete submission text file 0001193125-20-243083.txt   140132

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA itci-20200910.xsd EX-101.SCH 3112
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20200910_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20200910_pre.xml EX-101.PRE 10981
5 EXTRACTED XBRL INSTANCE DOCUMENT d938653d8k_htm.xml XML 3214
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 201168771
SIC: 2834 Pharmaceutical Preparations